Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema
- 1 October 1997
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 23 (8), 1183-1189
- https://doi.org/10.1016/s0886-3350(97)80313-6
Abstract
Purpose: To compare the efficacy and tolerance of diclofenac 0.1 % eyedrops with a regimen that included a brief course of steroids in the treatment of postoperative inflammation after extracapsular cataract surgery and posterior chamber intraocular lens implantation. A second objective was to compare the efficacy of diclofenac 0.1% eyedrops in the same patients and control group in preventing cystoid macular edema (CME). Setting: Eight university/hospital centers and one company in Italy. Methods: The multicenter, controlled, randomized, prospective, double-blind study included 281 patients. All were evaluated at baseline, at surgery, and after 1, 5, 36, 67, and 140 days. Postoperative inflammation was measured by the clinical assessment of inflammation: conjunctival hyperemia, ciliary flush, Tyndall effect, and cells in the anterior chamber. Fluorescein angiography was performed to evaluate the presence/absence of CME before surgery and after 36 and 140 days. Results: During follow-up, no differences in intraoperative pressure were observed within or between groups or between operated and fellow eyes. No statistically significant between-group differences in postoperative inflammation were found. After 36 days, angiographic CME was found in 9 patients (6.43%) in the diclofenac group and 20 (15.15%) in the control group (P = .033) with a relative risk for developing CME of 0.40 (Cl95 0.19 to 0.84). At the end of follow-up, it was found in 4 patients in the diclofenac group (3.31%) and 10 (9.26%) in the control group (P = .05) with a relative risk of 0.36 (Cl95 0.12 to 0.90). Conclusion: Diclofenac sodium was as effective as the control regimen in controlling postoperative inflammation after cataract surgery. It also had a protective effect on the development of angiographic CME after 36 and 140 days.Keywords
This publication has 11 references indexed in Scilit:
- A Comparison of Topical Diclofenac With Prednisolone for Postcataract InflammationAmerican Journal of Ophthalmology, 1995
- Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgeryJournal of Cataract & Refractive Surgery, 1994
- The effect of flurbiprofen 0.03% eye drops on the blood aqueous barrier in extracapsular cataract extraction with IOL implantationInternational Ophthalmology, 1991
- Inhibition of Blood-Aqueous Humor Barrier Breakdown With DiclofenacAmerican Journal of Ophthalmology, 1990
- The Quantitative Effect of 0.5% Ketorolac Tromethamine Solution and 0.1% Dexamethasone Sodium Phosphate Solution on Postsurgical Blood-Aqueous BarrierAmerican Journal of Ophthalmology, 1988
- Quantitative Assessment of Postsurgical Breakdown of the Blood-Aqueous Barrier Following Administration of 0.5% Ketorolac Tromethamine SolutionAmerican Journal of Ophthalmology, 1988
- Pharmacologic Therapy of Aphakic and Pseudophakic Cystoid Macular EdemaOphthalmology, 1985
- Prophylaxis and therapy of aphakic cystoid macular edemaSurvey of Ophthalmology, 1984
- Pharmacologic Therapy of Aphakic Cystoid Macular EdemaOphthalmology, 1982
- Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin.British Journal of Ophthalmology, 1980